Michael C Perry. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Small Cell/drug therapyCarcinoma, Small Cell/pathologyCarcinoma, Small Cell/radiotherapyChemotherapy, AdjuvantCisplatin/administration & dosageCyclophosphamide/administration & dosageDose Fractionation, RadiationDoxorubicin/administration & dosageEtoposide/administration & dosageHumansLondonLung Neoplasms/drug therapyLung Neoplasms/pathologyLung Neoplasms/radiotherapyMeta-Analysis as TopicMulticenter Studies as TopicNeoplasm StagingRadiotherapy, Adjuvant/methodsRandomized Controlled Trials as TopicSurvival AnalysisTime FactorsTreatment OutcomeVincristine/administration & dosage
Substances: See more » VincristineEtoposideDoxorubicinCyclophosphamideCisplatin
Year: 2006 PMID: 16921030 DOI: 10.1200/JCO.2006.07.2827
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544